CG logo

Carlyle (CG) EBITDA

annual EBITDA:

$1.70B+$1.58B(+1285.40%)
December 31, 2024

Summary

  • As of today (May 18, 2025), CG annual EBITDA is $1.70 billion, with the most recent change of +$1.58 billion (+1285.40%) on December 31, 2024.
  • During the last 3 years, CG annual EBITDA has fallen by -$2.67 billion (-61.14%).
  • CG annual EBITDA is now -61.14% below its all-time high of $4.37 billion, reached on December 31, 2021.

Performance

CG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGincome statement metrics

quarterly EBITDA:

$359.20M-$109.00M(-23.28%)
March 31, 2025

Summary

  • As of today (May 18, 2025), CG quarterly EBITDA is $359.20 million, with the most recent change of -$109.00 million (-23.28%) on March 31, 2025.
  • Over the past year, CG quarterly EBITDA has increased by +$37.80 million (+11.76%).
  • CG quarterly EBITDA is now -79.18% below its all-time high of $1.72 billion, reached on March 31, 2012.

Performance

CG quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGincome statement metrics

TTM EBITDA:

$2.30B+$37.80M(+1.67%)
March 31, 2025

Summary

  • As of today (May 18, 2025), CG TTM EBITDA is $2.30 billion, with the most recent change of +$37.80 million (+1.67%) on March 31, 2025.
  • Over the past year, CG TTM EBITDA has increased by +$2.18 billion (+1867.09%).
  • CG TTM EBITDA is now -47.35% below its all-time high of $4.37 billion, reached on December 31, 2021.

Performance

CG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1285.4%+11.8%+1867.1%
3 y3 years-61.1%-56.9%-41.9%
5 y5 years+12.3%+150.8%+774.8%

CG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-61.1%+1285.4%-65.0%+155.6%-41.9%+1867.1%
5 y5-year-61.1%+1285.4%-73.2%+150.8%-47.4%>+9999.0%
alltimeall time-61.1%+1285.4%-79.2%+150.8%-47.4%>+9999.0%

CG EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$359.20M(-23.3%)
$2.30B(+1.7%)
Dec 2024
$1.70B(+1285.4%)
$468.20M(-54.4%)
$2.26B(+97.0%)
Sep 2024
-
$1.03B(+129.9%)
$1.15B(+151.5%)
Jun 2024
-
$446.80M(+39.0%)
$456.90M(+290.5%)
Mar 2024
-
$321.40M(-149.7%)
$117.00M(-4.6%)
Dec 2023
$122.60M(-94.0%)
-$646.30M(-292.9%)
$122.60M(-88.7%)
Sep 2023
-
$335.00M(+213.4%)
$1.09B(-11.9%)
Jun 2023
-
$106.90M(-67.3%)
$1.24B(-19.6%)
Mar 2023
-
$327.00M(+2.5%)
$1.54B(-24.8%)
Dec 2022
$2.04B(-53.3%)
$319.10M(-33.9%)
$2.04B(-25.1%)
Sep 2022
-
$482.40M(+18.3%)
$2.73B(-10.1%)
Jun 2022
-
$407.70M(-51.0%)
$3.03B(-23.5%)
Mar 2022
-
$832.70M(-16.9%)
$3.96B(-9.4%)
Dec 2021
$4.37B(+391.4%)
$1.00B(+27.3%)
$4.37B(+5.5%)
Sep 2021
-
$787.50M(-41.1%)
$4.14B(+7.8%)
Jun 2021
-
$1.34B(+7.6%)
$3.84B(+35.3%)
Mar 2021
-
$1.24B(+60.8%)
$2.84B(+219.2%)
Dec 2020
$889.60M(-41.2%)
$772.90M(+58.3%)
$889.60M(+484.9%)
Sep 2020
-
$488.20M(+45.6%)
$152.10M(-3480.0%)
Jun 2020
-
$335.40M(-147.4%)
-$4.50M(-101.7%)
Mar 2020
-
-$706.90M(-2096.9%)
$263.10M(-82.6%)
Dec 2019
$1.51B(+131.4%)
$35.40M(-89.3%)
$1.51B(+2.6%)
Sep 2019
-
$331.60M(-45.0%)
$1.47B(+15.0%)
Jun 2019
-
$603.00M(+11.1%)
$1.28B(+27.3%)
Mar 2019
-
$542.90M(<-9900.0%)
$1.01B(+54.0%)
Dec 2018
$653.90M(-60.1%)
-$3.60M(-102.6%)
$653.90M(-41.4%)
Sep 2018
-
$139.80M(-57.3%)
$1.12B(-12.2%)
Jun 2018
-
$327.70M(+72.5%)
$1.27B(-3.0%)
Mar 2018
-
$190.00M(-58.6%)
$1.31B(-20.0%)
DateAnnualQuarterlyTTM
Dec 2017
$1.64B(+218.5%)
$459.20M(+55.5%)
$1.64B(+24.4%)
Sep 2017
-
$295.30M(-19.6%)
$1.32B(+17.5%)
Jun 2017
-
$367.20M(-29.0%)
$1.12B(+19.6%)
Mar 2017
-
$517.50M(+277.2%)
$937.00M(+82.0%)
Dec 2016
$514.70M(-73.8%)
$137.20M(+39.0%)
$514.70M(-5.2%)
Sep 2016
-
$98.70M(-46.2%)
$542.70M(+16.3%)
Jun 2016
-
$183.60M(+92.9%)
$466.80M(-57.0%)
Mar 2016
-
$95.20M(-42.4%)
$1.08B(-44.9%)
Dec 2015
$1.97B(-19.9%)
$165.20M(+624.6%)
$1.97B(-2.5%)
Sep 2015
-
$22.80M(-97.2%)
$2.02B(-19.3%)
Jun 2015
-
$801.30M(-18.0%)
$2.50B(-3.1%)
Mar 2015
-
$977.60M(+353.4%)
$2.58B(+5.0%)
Dec 2014
$2.46B(-4.7%)
$215.60M(-57.3%)
$2.46B(-24.5%)
Sep 2014
-
$505.00M(-42.7%)
$3.26B(+7.6%)
Jun 2014
-
$880.90M(+3.0%)
$3.03B(+13.0%)
Mar 2014
-
$855.50M(-15.6%)
$2.68B(+3.8%)
Dec 2013
$2.58B(-22.6%)
$1.01B(+268.7%)
$2.58B(+33.1%)
Sep 2013
-
$275.00M(-48.3%)
$1.94B(-22.5%)
Jun 2013
-
$532.10M(-29.7%)
$2.50B(+5.8%)
Mar 2013
-
$756.50M(+102.7%)
$2.36B(-29.1%)
Dec 2012
$3.33B(+87.1%)
$373.20M(-55.4%)
$3.33B(-13.9%)
Sep 2012
-
$836.50M(+111.3%)
$3.87B(+51.6%)
Jun 2012
-
$395.80M(-77.1%)
$2.55B(-2.3%)
Mar 2012
-
$1.72B(+89.7%)
$2.61B(+46.7%)
Dec 2011
$1.78B(+1.4%)
$909.10M(-289.4%)
$1.78B(+104.4%)
Sep 2011
-
-$480.00M(-205.2%)
$870.50M(-35.5%)
Jun 2011
-
$456.40M(-49.0%)
$1.35B(+51.0%)
Mar 2011
-
$894.10M
$894.10M
Dec 2010
$1.76B(+137.7%)
-
-
Dec 2009
$738.30M
-
-

FAQ

  • What is Carlyle annual EBITDA?
  • What is the all time high annual EBITDA for Carlyle?
  • What is Carlyle annual EBITDA year-on-year change?
  • What is Carlyle quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Carlyle?
  • What is Carlyle quarterly EBITDA year-on-year change?
  • What is Carlyle TTM EBITDA?
  • What is the all time high TTM EBITDA for Carlyle?
  • What is Carlyle TTM EBITDA year-on-year change?

What is Carlyle annual EBITDA?

The current annual EBITDA of CG is $1.70B

What is the all time high annual EBITDA for Carlyle?

Carlyle all-time high annual EBITDA is $4.37B

What is Carlyle annual EBITDA year-on-year change?

Over the past year, CG annual EBITDA has changed by +$1.58B (+1285.40%)

What is Carlyle quarterly EBITDA?

The current quarterly EBITDA of CG is $359.20M

What is the all time high quarterly EBITDA for Carlyle?

Carlyle all-time high quarterly EBITDA is $1.72B

What is Carlyle quarterly EBITDA year-on-year change?

Over the past year, CG quarterly EBITDA has changed by +$37.80M (+11.76%)

What is Carlyle TTM EBITDA?

The current TTM EBITDA of CG is $2.30B

What is the all time high TTM EBITDA for Carlyle?

Carlyle all-time high TTM EBITDA is $4.37B

What is Carlyle TTM EBITDA year-on-year change?

Over the past year, CG TTM EBITDA has changed by +$2.18B (+1867.09%)
On this page